GRB-treated mice exhibited higher toxicity levels to YAC-1 cells compared to untreated mice indicating that the tumor inhibitory effect of GRB is through NK cell activation; NK cells suppress tumor growth and metastasis [157]. The gene discussed is GZMB; the disease is neoplasm.